Tag Archives: payers

For Becton Dickinson, Medication Errors are a Business Opportunity

By Ben Comer | Published: April 1, 2013
Over the next few years, med tech company Becton Dickinson will launch up to 30 generic, pre-filled syringes in an attempt to lower medication errors and raise company revenues, according to BD Rx president Mark Sebree. One man’s goof is another man’s growth, potentially.
Posted in FDA, Manufacturing, R&D, Safety, Strategy, Technology, pricing | Also tagged , , , , | Leave a comment

Prix Galien: Pharma R&D and Payers Need to Talk, Yesterday

By Ben Comer | Published: September 28, 2011
R&D departments and payers need to communicate early in the drug development process: If pharma is a day late, then payers are likely to be a dollar short, according to panelists at the Galien Forum on Tuesday.
Posted in FDA, Market Access, R&D, Strategy, leadership, pricing | Also tagged , , , | Leave a comment

Fixing Biotech's Broken Business Model

By Julian Upton | Published: December 22, 2010
Despite some notable successes, the global biotech industry has fallen short of expectations. Strategic collaborations have been on the increase, but there is now a need for more co-operation using new collaboration models, writes Jo Pisani. The current business model on which biotech has relied is flawed. Due to poor rates of return, investment has dried [...]
Posted in Biotech, Deals, Emerging Markets, Europe, Global, Guest Blog, R&D | Also tagged , , , , , , , | Leave a comment